Skip to content
People

Michael Aceti

Executive Officer at X1 Biotech.

Earliest Form D on file: Jun 2026

Filed Jun 15, 2026

X1 Biotech

RUNX1 inhibitor for inherited small-vessel brain disease

Biotech, Needham MA

Named, Executive Officer.

$40K

sold of $2M offered

Form D

Network

At X1 Biotech

5 people